Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Programme for academic year 2010 to 2011

Note: Details about the seminar programme have not been updated and may be incomplete

  • Michaelmas 2010 (Oct to Dec)

  • 12 Oct   Dr Peter Campbell, Sanger Institute, Cambridge: Genetics of lung cancer in the context of smoking
  • 19 Oct    Professor Nilesh Samani, University of Leicester: New insights into the genetic basis of coronary artery disease
  • 26 Oct    Sir Iain Chalmers, James Lind Library, Oxford: Controlled trials before randomisation
  • 2 Nov     Professor David Matthews, OCDEM, University of Oxford: Oxford Health Alliance
  • 9 Nov     NO SEMINAR
  • 16 Nov    Professor Doug Altman and Dr Iveta Simera, University of Oxford: EQUATOR
  • 23 Nov    Professor Ian Roberts, London School of Hygiene and Tropical Medicine: Treating Severe Haemorrhage
  • 30 Nov    Professor Dame Valerie Beral and Dr Jane Green, Cancer Epidemiology Unit, University of Oxford: Hormonal factors in Ovarian Cancer and Cancer of the Gastrointestinal Tract and HRT
  • 7 Dec      Professor Sir Richard Peto, CTSU, University of Oxford: Treatment of early breast cancer: new EBCTG results


Hilary 2011 (jan to mar)

  • 18 Jan    NO SEMINAR
  • 25 Jan    Professor John Walley, Nuffield Centre for International Health and Development, University of Leeds: Getting service delivery research into practice at scale in low-middle income countries
  • 1 Feb      Professor Andrew Hall, London School of Hygiene and Tropical Medicine: Hepatocellular carcinoma prevention: progress and barriers
  • 8 Feb     Dr Gary Fooks, University of Bath: Understanding Contemporary Trends in Corporate Influence over Public health Policy. What can we learn from Corporate Social Responsibility in the Tobacco Industry?
  • 15 Feb    Professor Sir Rory Collins, CTSU, University of Oxford: UK Biobank: a 500,000 person resource for health research
  • 22 Feb    Dr Leanne Hodson, OCDEM, University of Oxford: Heaptic fatty acid partitioning: the art of tracing dietary fat in humans
  • 1 Mar      NO SEMINAR
  • 8 Mar      Professor Sarah Darby and Dr Paul McGale, CTSU, University of Oxford: Smoking-related mortality in Japan


Trinity 2011 (Apr to Jun)

  • 3 May     Professor Sally Macintyre, Social and Public Health Sciences Unit, University of Glasgow: Evaluating the effects on health and behaviour of natural experiments
  • 10 May    Dr Trudie Lang, Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford: Global Health Clinical Trials: An Online Research Community
  • 17 May    Dr David Heymann, Health Protection Agency: Molecular epidemiology in public health: the good, the bad and the evil
  • 24 May    Dr Robert Clarke, CTSU, University of Oxford: Folic acid, homocysteine and prevention of cardiovascular disease
  • 31 May    Professor Michael Goldacre, Department of Public Health, University of Oxford: Some uses of record linkage in epidemiological and health services research
  • 7 Jun       Professor John Oates, Vanderbilt University Medical Center: Metabolic syndrome associates with resistance to aspirin in patients with coronary artery disease
  • 14 Jun     Professor Sir Nick Wald, Wolfson Institute of Preventive Medicine, University of London: Nutrition in prevention: time for SASS tax
  • 21 Jun     NO SEMINAR